Relationship between circulating insulin-like growth factor components and sex hormones in a population-based sample of 50- to 80-year-old men and women

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 7, 1996, Pages 2534-2540

  Pfeilschifter, Johannes ^a   Scheidt Nave, Christa ^a   Leidig Bruckner, Gudrun ^a   Woitge, Henning W ^a   Blum, Werner F ^b   Wüster, Christian ^a   Haack, Doris ^a   Ziegler, Reinhard ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b LILLY DEUTSCHLAND GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTANEDIOL; ESTRADIOL; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; SEX HORMONE BINDING PROTEIN; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TESTOSTERONE;

ADULT; AGED; ANDROGEN BLOOD LEVEL; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE GROWTH; BONE MINERAL; ESTRADIOL BLOOD LEVEL; FEMALE; HORMONE ACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENOPAUSE; PRIORITY JOURNAL; REGULATORY MECHANISM; TESTOSTERONE BLOOD LEVEL; TISSUE METABOLISM;

AGED; AGED, 80 AND OVER; ANDROSTANE-3,17-DIOL; BONE DENSITY; FEMALE; GONADAL STEROID HORMONES; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MALE; MIDDLE AGED; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE;

EID: 0030011396     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.7.2534     Document Type: Article

References (58)

1. Daughaday WH, Rotwein P. 1989 Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr Rev. 10:68-91.
2. Langford KS, Miell JP. 1993 The insulin-like growth factor-I/binding protein axis: physiology, pathophysiology and therapeutic manipulation. Eur J Clin Invest. 23:503-516.
3. Jones JI, Clemmons DR. 1995 Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev. 16:3-34.
4. D'Ercole AJ, Stiles AD, Underwood LE. 1984 Tissue concentrations of somatomedin C; further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. Proc Natl Acad Sci USA. 81:935-939.
5. Salmon WD, Daughaday WH. 1957 A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. J Lab Clin Med. 49:825-836.
6. Kerrigan JR, Rogol AD. 1992 The impact of gonadal steroid action on growth hormone secretion during childhood and adolescence. Endocr Rev. 13:281-298.
7. Venneulen A. 1991 Androgens in the aging male. J Clin Endocrinol Metab. 73:221-224.
8. Irarunanesh A, Lizzarralde G, Veldhuis JD. 1991 Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J Clin Endocrinol Metab. 73:1081-1088.
9. Corpas E, Harman SM, Pineyro MA, Robertson R, Blackman MR. 1992 Growth hormone (GH)-releasing hormone 1-29 twice daily reverses the decreased GH and insulin-like growth factor I levels in old men. J Clin Endocrinol Metab. 75:530-535.
10. Lonning PE, Helle S-I, Johannessen DG, et al. 1995 Reactions between sex hormones, sex hormone-binding globulin, insulin-like growth fartor-I and insulin-like growth factor-binding protein-1 in postmenopausal breast cancer patients. Clin Endocrinol. 42:23-30.
11. Ho KY, Evans WS, Blizzard RM, et al. 1987 Effects of sex and age on 24-hour profile of growth hormone secretion in men: importance of endogenous es-tradiol concentrations. J Clin Endocrinol Metab. 64:51-58.
12. Lang I, Schernthaner G, Pietschmann P, Kurz R, Stephenson JM, Tempi M. 1987 Effects of sex and age on growth hormone response to growth hormone-releasing hormone in healthy individuals. J Clin Endocrinol Metab. 65:535-540.
13. Ho KKY, Weissberger AJ. 1992 Impact of short-term estrogen administration on growth hormone secretion and action: distinct route-dependent effects on connective and bone tissue metabolism. J Bone Miner Res. 7:821-827.
14. Massa G, lgout A, Rombauts L, Frankenne F, Vanderschueren-Lodeweyckx M. 1993 Effect of oestrogen status on serum levels of growth hormone-binding protein and insulin-like growth factor I in nonpregnant and pregnant women. Clin Endocrinol. 39:569-575.
15. Duursma SA. 1984 Changes in serum somatomedin and growth hormone concentrations after 3 weeks oestrogen substitution in postmenopausal women: a pilot study. Acta Endocrinol. 166:527-531.
16. Dawson-Hughes B, Stern D, Goldman J, Reichlin S. 1986 Regulation of growth hormone and somatomedin-C secretion in postmenopausal women: effect of physiological estrogen replacement. J Clin Endocrinol Metab. 63:424-432.
17. Bellantoni MF, Harman SM, Cho D, Blackman MR. 1991 Effects of progestin-opposed transdermal estrogen administration on growth hormone and insulin-like growth factor I in postmenopausal women of different ages. J Clin Endocrinol Metab. 72:172-178.
18. Weissberger AJ, Ho KKY, Lazarus L. 1991 Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women. J Clin Endocrinol Metab. 72:374-381.
19. Kelly JJ, Rajkovic IA, O'Sullivan AJ, Sernia C, Ho KKY. 1993 Effects of different oral oestrogen formulations on insulin-like growth factor I, growth hormone and growth hormone-binding protein in postmenopausal women. Clin Endocrinol. 39:561-567.
20. Dall'Aglio E, Valenti G, Horffman AR, Zuccarelli A, Passen M, Ceda GP. 1994 Lack of effect of transdermal estrogen on the growth hormone insulin-like growth factor axis. Horm Metab Res. 26:211-212.
21. Blum WF, Breier BH. 1994 Radioimmunoassays for IGFs and IGFBPs. Growth Regul. [Suppl 1]4:11-19.
22. Blum WF, Ranke MB, Bierich JR. 1988 A specific radioimmunoassay for insulin-like growth factor II: the interference of IGF-binding proteins can be blocked by excess IGF-I. Acta Endocrinol. 118:374-380.
23. Auletta FJ, Caldwell BV, Hamilton GL. 1979 Androgens: testosterone and dihydrotestosterone. In: Jaffe BM, Behrman HR, eds. Methods of hormone radioimmunoassay. New York: Academic Press; 715-726.
24. Vecsei P. 1979 Glucocorticoids: Cortisol, cortisone, corticosterone, compound S, and their metabolites. In: Jaffe BM, Behrman HR, eds. Methods of hormone radioimmunoassay. New York: Academic Press; 767-792.
25. Nankin HR, Pinto R, Fan D-F, Troen P. 1975 Daytime titers of testosterone, luteinizing hormone (LH), estrone, estradiol, and testosterone-binding protein: acute effects of LH and LH-releasing hormone in men. J Clin Endocrinol Metab. 41:271-281.
26. Deslypere J-P, Sayed A, Punjabi U, Verdonck L, Vermeulen A. 1982 Plasma 5α-androstane-3α,17β-diol and urinary 5α-androstane-3α,17β-diol glucuronide, parameters of peripheral androgen action: a comparative study. J Clin Endocrinol Metab. 54:386-391.
27. Haack D. 1979 Die Gewinnung von Antiseren für den Radioimmunoassay. Medizintechnik. 90:92-98.
28. Pearson J., Dequeker J., Reeve J., et al. 1995 Dual x-ray absorptiometry of the proximal femur: normal European values standardized with the European spine phantom. J Bone Miner Res. 10:315-324.
29. Brody S, Carlström K, Lagrelius A, Lunell N-O, Möllerström G, Pousette A. 1987 Serum sex hormone-binding globulin (SHBG), testosterone/SHBG index, endometrial pathology and bone mineral density in postmenopausal women. Acta Obstet Gynecol Scand. 66:357-360.
30. Van Hemert AM, Birkenhäger JC, De Jong FH, Vandenbroucke JP, Valkenburg HA. 1989 Sex hormone-binding globulin in postmenopausal women: a predictor of osteoporosis superior to endogenous oestrogens. Clin Endocrinol. 31:499-509.
31. Martin LG, Clark JW, Conner TB. 1968 Growth hormone secretion enhanced by androgens. J Clin Endocrinol Metab. 28:425-431.
32. Illig R, Prader A. 1970 Effect of testosterone on growth hormone secretion in patients with anorchia and delayed puberty. J Clin Endocrinol Metab. 30:615-622.
33. Parker MW, Johanson AJ, Rogol AD, Kaiser DL, Blizzard RM. 1984 Effect of testosterone on somatomedin-C concentrations in prepubertal boys. J Clin Endocrinol Metab. 58:87-90.
34. Rosenfield RL, Furlanetto RW. 1985 Physiologic testosterone or estradiol induction of puberty increases plasma somatomedin-C. J Pediatr. 107:415-417.
35. Liu L, Merriam GR, Sherins RJ. 1987 Chronic sex steroid exposure increases mean plasma growth hormone concentration and pulse amplitude in men with isolated hypogonadotrophic hypogonadism. J Clin Endocrinol Metab. 64:651-656.
36. Hobbs CJ, Plymate SR, Rosen CJ, Adler RA. 1993 Testosterone administration increases insulin-like growth factor I levels in normal men. J Clin Endocrinol Metab. 77:776-779.
37. Azziz R, Deal CL, Potter HD, Gargosky SE, Rosenfeld RG. 1994 Regulation of extragonadal insulin-like growth factor-binding protein-3 by testosterone in oophorectomized women. J Clin Endocrinol Metab. 79:1747-1751.
38. Jansson J-O, Eden S, Isaksson O. 1983 Sites of action of testosterone and estradiol on longitudinal bone growth. Am J Physiol. 244:E135-E140.
39. Ceda GP, Ceresini G, Denti L, Cortellini P, Huffman AR, Valenti G. 1989 Androgens do not regulate the growth hormone response to GHRH in elderly men. Horm Metab Res. 21:695-696.
40. Cara JF, Rosenfield RL. 1988 Insulin-like growth factor I and insulin potentiate luteinizing hormone-induced androgen synthesis by rat ovarian thecal-interstitial cells. Endocrinology. 123:733-739.
41. Hernandez ER, Resnick CE, Svoboda ME, Van Wyk JJ, Payne DW, Adashi EY. 1988 Somatomedin-C/insulin-like growth factor I as an enhancer of androgen biosynthesis by cultured rat ovarian cells. Endocrinology. 122:1603-1612.
42. Kanematsu T, Irahara M, Miyake T, Shitsukawa K, Aono T. 1991 Effect of insulin-like growth factor I on gonadotropin release from hypothalamus-pituitary axis in vitro. Acta Endocrinol. 125:227-233.
43. Chandrashekar V, Bartke A. 1993 Induction of endogenous insulin-like growth factor 1 secretion alters the hypothalamic-pituitary-testicular function in growth hormone-deficient adult dwarf mice. Biol Reprod. 48:544-551.
44. von Schoultz B, Carlström K. 1989 On the regulation of sex-hormone-binding globulin - a challenge of an old dogma and outlines of an alternative mechanism. J Steroid Biochem. 32:327-334.
45. Toscano V, Balducci R, Bianchi P, Guglielmi R, Mangiantini A, Sciarra F. 1992 Steroidal and nonsteroidal factors in plasma sex hormone-binding globulin regulation. J Steroid Biochem Mol Biol. 43:431-437.
46. Apter D, Bolton NJ, Hammond GL, Vihko R. 1984 Serum sex hormone-binding globulin during puberty in girls and in different types of adolescent menstrual cycles. Acta Endocrinol. 107:413-419.
47. Belgorosky A, Rivarola MA. 1986 Progressive decrease in serum sex hormone-binding globulin from infancy to late prepuberty in boys. J Clin Endocrinol Metab. 63:510-512.
48. Cunningham SK, Loughlin T, Culliton M, McKenna TJ. 1984 Plasma sex hormone-binding globulin levels decrease during the second decade of life irrespective of pubertal status. J Clin Endcrinol Metab. 58:915-918.
49. Belgorosky A, Martinez A, Domene H, Heinrich JJ, Bergada C, Rivarola MA. 1987 High serum sex hormone-binding globulin (SHBG) and non-SHBG-bound testosterone in boys with idiopathic hypopituitarism: effect of recombinant human growth hormone treatment. J Clin Endocrinol Metab. 65:1107-1111.
50. Plymate SR, Matej LA, Jones RE, Friedl KE. 1988 Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. J Clin Endocrinol Metab. 67:460-464.
51. Hoist J, Cajander S, Carlström K, Damber M-G, von Schoultz B. 1983 A comparison of liver protein induction in postmenopausal women during oral and percutaneous oestrogen replacement therapy. Br J Obstet Gynaecol. 90:355-360.
52. Wilshire GB, Loughlin JS, Brown JR, Adel TE, Santoro N. 1995 Diminished function of the somatotropic axis in older reproductive-aged women. J Clin Endocrinol Metab. 80:608-613.
53. Lien EA, Johannessen DC, Aakvag A, Lonning PE. 1992 Influence of tamoxifen, aminoglutethimide and goselerin on human plasma IGF-I levels in breast cancer patients. J Steroid Biochem Mol Biol. 41:541-543.
54. Reed MJ, Topping L, Coldham NG, Purohit A, Ghilchik MW, James VHT. 1993 Control of aromatase activity in breast cancer cells: the role of cytokines and growth factors. J Steroid Biochem Mol Biol. 44:589-596.
55. Cara JF. 1994 Insulin-like growth factors, insulin-like growth factor-binding proteins and ovarian androgen production. Horm Res. 42:49-54.
56. Poretsky L. 1991 On the paradox of insulin-induced hyperandrogenism in insulin-resistant states. Endocr Rev. 12:3-13.
57. Rosen CJ, Donahue LR, Hunter SJ. 1994 Insulin-like growth factors and bone, the osteoporosis connection. Proc Soc Exp Biol Med. 206:83-102.
58. Wüster C. 1995 Growth hormone, insulin-like growth factors and bone metabolism. Endocrinology and Metabolism. 2:3-12.